280 related articles for article (PubMed ID: 32007101)
1. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators.
Lindsay A; Baumann CW; Rebbeck RT; Yuen SL; Southern WM; Hodges JS; Cornea RL; Thomas DD; Ervasti JM; Lowe DA
Skelet Muscle; 2020 Feb; 10(1):3. PubMed ID: 32007101
[TBL] [Abstract][Full Text] [Related]
2. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
[TBL] [Abstract][Full Text] [Related]
3. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of weakness in Mdx muscle following in vivo eccentric contractions.
Baumann CW; Ingalls CP; Lowe DA
J Muscle Res Cell Motil; 2022 Jun; 43(2):63-72. PubMed ID: 35445349
[TBL] [Abstract][Full Text] [Related]
5. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
6. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
7. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.
Nogami K; Maruyama Y; Sakai-Takemura F; Motohashi N; Elhussieny A; Imamura M; Miyashita S; Ogawa M; Noguchi S; Tamura Y; Kira JI; Aoki Y; Takeda S; Miyagoe-Suzuki Y
Hum Mol Genet; 2021 May; 30(11):1006-1019. PubMed ID: 33822956
[TBL] [Abstract][Full Text] [Related]
10. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
11. Plasmalemma Function Is Rapidly Restored in Mdx Muscle after Eccentric Contractions.
Baumann CW; Warren GL; Lowe DA
Med Sci Sports Exerc; 2020 Feb; 52(2):354-361. PubMed ID: 31415447
[TBL] [Abstract][Full Text] [Related]
12. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice.
Whitehead NP; Pham C; Gervasio OL; Allen DG
J Physiol; 2008 Apr; 586(7):2003-14. PubMed ID: 18258657
[TBL] [Abstract][Full Text] [Related]
13. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
14. Complementary NAD
Frederick DW; McDougal AV; Semenas M; Vappiani J; Nuzzo A; Ulrich JC; Becherer JD; Preugschat F; Stewart EL; Sévin DC; Kramer HF
Skelet Muscle; 2020 Oct; 10(1):30. PubMed ID: 33092650
[TBL] [Abstract][Full Text] [Related]
15. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
16. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
[TBL] [Abstract][Full Text] [Related]
17. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
[TBL] [Abstract][Full Text] [Related]
18. Intracellular calcium handling in ventricular myocytes from mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H846-55. PubMed ID: 17012353
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
Kunert-Keil CH; Gredes T; Lucke S; Botzenhart U; Dominiak M; Gedrange T
J Physiol Pharmacol; 2014 Apr; 65(2):317-24. PubMed ID: 24781740
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
